UY35003A - Nanopartícula polimérica de finasterida, suspensión acuosa conteniendo a la misma, composición para tratamiento de alopecia,proceso de preparación de dicha composición, y su uso - Google Patents
Nanopartícula polimérica de finasterida, suspensión acuosa conteniendo a la misma, composición para tratamiento de alopecia,proceso de preparación de dicha composición, y su usoInfo
- Publication number
- UY35003A UY35003A UY0001035003A UY35003A UY35003A UY 35003 A UY35003 A UY 35003A UY 0001035003 A UY0001035003 A UY 0001035003A UY 35003 A UY35003 A UY 35003A UY 35003 A UY35003 A UY 35003A
- Authority
- UY
- Uruguay
- Prior art keywords
- composition
- finasterida
- preparation process
- same
- alopecia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/044—Suspensions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/85—Polyesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/654—The particulate/core comprising macromolecular material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
La presente invención tiene el objetivo de proporcionar una composición farmacéutica para el tratamiento de la alopecia, dicha composición contiene nanopartículas poliméricas, preferencialmente nanocápsulas, conteniendo finasterida, aditivos y vehículo farmacéuticamente aceptables, así como el uso de las nanopartículas para preparar dicha composición para el tratamiento de la alopecia. La invención incluye además un proceso de preparación de nanocápsulas de finasterida apropiadas para una composición de vehículo tópico para el tratamiento de la alopecia.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102012022034-2A BR102012022034B1 (pt) | 2012-08-31 | 2012-08-31 | Nanopartícula polimérica de finasterida, suspensão aquosa contendo a mesma, composição para tratamento de alopecia, processo de preparação de dita composição, e seu uso |
Publications (1)
Publication Number | Publication Date |
---|---|
UY35003A true UY35003A (es) | 2014-03-31 |
Family
ID=50182295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001035003A UY35003A (es) | 2012-08-31 | 2013-08-30 | Nanopartícula polimérica de finasterida, suspensión acuosa conteniendo a la misma, composición para tratamiento de alopecia,proceso de preparación de dicha composición, y su uso |
Country Status (21)
Country | Link |
---|---|
US (1) | US9895302B2 (es) |
EP (1) | EP2891487B1 (es) |
JP (1) | JP6235018B2 (es) |
KR (1) | KR102128478B1 (es) |
CN (1) | CN104768539B (es) |
AR (1) | AR092402A1 (es) |
AU (1) | AU2013308355B2 (es) |
BR (1) | BR102012022034B1 (es) |
CA (1) | CA2883996C (es) |
CL (1) | CL2015000502A1 (es) |
DK (1) | DK2891487T3 (es) |
ES (1) | ES2702577T3 (es) |
IN (1) | IN2015DN01727A (es) |
MX (1) | MX357601B (es) |
PE (2) | PE20191713A1 (es) |
SA (1) | SA515360083B1 (es) |
TR (1) | TR201818992T4 (es) |
UA (1) | UA116993C2 (es) |
UY (1) | UY35003A (es) |
WO (1) | WO2014032151A1 (es) |
ZA (1) | ZA201501254B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2596720B1 (es) * | 2015-07-10 | 2018-01-29 | Juvilis Cosmetics S.L. | Composiciones para uso tópico |
KR102429536B1 (ko) * | 2015-09-30 | 2022-08-04 | (주)아모레퍼시픽 | 열안정성 현탁 화장료 조성물 |
JP6960937B2 (ja) | 2016-03-08 | 2021-11-05 | リビング プルーフ インコーポレイテッド | 長期持続性化粧品組成物 |
MY189759A (en) | 2016-03-18 | 2022-03-02 | Caregen Co Ltd | Conjugate of finasteride with peptide |
JPWO2018180966A1 (ja) * | 2017-03-28 | 2019-06-27 | 富士フイルム株式会社 | マイクロカプセル及びその製造方法 |
WO2018206077A1 (en) * | 2017-05-08 | 2018-11-15 | Merz Pharma Gmbh & Co. Kgaa | Emulsion comprising finasteride |
JP7244495B2 (ja) | 2017-09-13 | 2023-03-22 | リビング プルーフ インコーポレイテッド | 長期持続性の化粧品組成物 |
WO2019055445A2 (en) | 2017-09-13 | 2019-03-21 | Living Proof, Inc. | COLOR PROTECTION COMPOSITIONS |
CA3084488A1 (en) | 2017-11-20 | 2019-05-23 | Living Proof, Inc. | Properties for achieving long-lasting cosmetic performance |
JP2021522260A (ja) | 2018-04-27 | 2021-08-30 | リビング プルーフ インコーポレイテッド | 長持ちする化粧用組成物 |
CN110448525A (zh) * | 2018-05-08 | 2019-11-15 | 无锡派列博生物医药科技有限公司 | 一种预防脱发和促生发的外用非那雄胺脂质纳米制剂及其制备方法 |
KR102644611B1 (ko) | 2018-11-29 | 2024-03-07 | (주)아모레퍼시픽 | 탈모 또는 피부 염증 억제용 조성물 |
KR20200099901A (ko) * | 2019-02-15 | 2020-08-25 | (주)인벤티지랩 | 피나스테라이드를 포함하는 마이크로 입자를 함유한 피하 주사용 조성물 |
KR102157124B1 (ko) * | 2019-12-23 | 2020-09-18 | (주)인벤티지랩 | 피나스테라이드를 포함하는 서방성 주사용 조성물 |
AU2021272476A1 (en) * | 2020-05-13 | 2022-12-15 | Follicle Pharma Ltd | Compositions for delivery of bioactive agents into hair follicles |
US20230372437A1 (en) * | 2020-09-24 | 2023-11-23 | Protransit Nanotherapy Llc | Compositions and methods for the treatment of hair loss and other conditions |
GB2624638A (en) * | 2022-11-22 | 2024-05-29 | Landa Labs 2012 Ltd | Nano-Carriers for Drug Delivery and Methods of Preparing the Same |
CN115400085A (zh) * | 2022-09-02 | 2022-11-29 | 南昌大学 | 一种非那雄胺类脂囊泡及其制备方法和应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4900984B2 (ja) * | 1997-07-15 | 2012-03-21 | 武田薬品工業株式会社 | 徐放性製剤の製造法 |
WO2005000258A1 (en) * | 2003-06-27 | 2005-01-06 | Amorepacific Corporation | Self-assembled polymeric nanoparticles containing physiologically active ingredients and external application containing the nanoparticles |
JP4939936B2 (ja) * | 2003-06-27 | 2012-05-30 | 株式會社アモーレパシフィック | 生理活性成分を含有する自己集合性高分子ナノ粒子の製造方法、及び得られた自己集合性高分子ナノ粒子を含有する外用剤組成物 |
WO2006099121A2 (en) | 2005-03-10 | 2006-09-21 | Elan Pharma International Limited | Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof |
US20080175807A1 (en) | 2007-01-24 | 2008-07-24 | Fujifilm Corporation | Composition for hair |
JP2009096787A (ja) * | 2007-10-19 | 2009-05-07 | Fujifilm Corp | 血行促進剤を内包した水分散可能なナノ粒子 |
FR2930176B1 (fr) * | 2008-04-18 | 2011-03-18 | Univ Claude Bernard Lyon | Nouveau procede de fabrication de nanocapsules, en l'absence de solvant organique, et nanocapsules ainsi obtenues |
EP2344198B1 (en) * | 2008-09-27 | 2020-11-04 | Jina Pharmaceuticals Inc. | Lipid based pharmaceutical preparations for topical application |
US20110195030A1 (en) * | 2008-10-15 | 2011-08-11 | The University Of North Carolina At Chapel Hill | Nanoparticle compositions comprising liquid oil cores |
CN102423297B (zh) * | 2011-12-23 | 2013-11-20 | 厦门金达威集团股份有限公司 | 一种自微乳液及其制备方法 |
-
2012
- 2012-08-31 BR BR102012022034-2A patent/BR102012022034B1/pt active IP Right Grant
-
2013
- 2013-08-30 TR TR2018/18992T patent/TR201818992T4/tr unknown
- 2013-08-30 WO PCT/BR2013/000334 patent/WO2014032151A1/pt active Application Filing
- 2013-08-30 MX MX2015002299A patent/MX357601B/es active IP Right Grant
- 2013-08-30 PE PE2019001938A patent/PE20191713A1/es unknown
- 2013-08-30 CA CA2883996A patent/CA2883996C/en active Active
- 2013-08-30 UY UY0001035003A patent/UY35003A/es not_active Application Discontinuation
- 2013-08-30 AR ARP130103102A patent/AR092402A1/es not_active Application Discontinuation
- 2013-08-30 AU AU2013308355A patent/AU2013308355B2/en not_active Ceased
- 2013-08-30 US US14/424,662 patent/US9895302B2/en active Active
- 2013-08-30 JP JP2015528814A patent/JP6235018B2/ja active Active
- 2013-08-30 EP EP13832319.1A patent/EP2891487B1/en active Active
- 2013-08-30 CN CN201380057187.2A patent/CN104768539B/zh active Active
- 2013-08-30 DK DK13832319.1T patent/DK2891487T3/en active
- 2013-08-30 ES ES13832319T patent/ES2702577T3/es active Active
- 2013-08-30 KR KR1020157008182A patent/KR102128478B1/ko active IP Right Grant
- 2013-08-30 PE PE2015000269A patent/PE20150731A1/es not_active Application Discontinuation
- 2013-08-30 UA UAA201502761A patent/UA116993C2/uk unknown
- 2013-08-30 IN IN1727DEN2015 patent/IN2015DN01727A/en unknown
-
2015
- 2015-02-24 ZA ZA2015/01254A patent/ZA201501254B/en unknown
- 2015-02-26 SA SA515360083A patent/SA515360083B1/ar unknown
- 2015-02-27 CL CL2015000502A patent/CL2015000502A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2015526483A (ja) | 2015-09-10 |
UA116993C2 (uk) | 2018-06-11 |
US20150238406A1 (en) | 2015-08-27 |
BR102012022034B1 (pt) | 2020-02-18 |
KR20150046332A (ko) | 2015-04-29 |
TR201818992T4 (tr) | 2019-01-21 |
AU2013308355A1 (en) | 2015-04-16 |
CN104768539A (zh) | 2015-07-08 |
EP2891487B1 (en) | 2018-11-28 |
SA515360083B1 (ar) | 2017-03-01 |
CL2015000502A1 (es) | 2015-10-16 |
CA2883996C (en) | 2020-10-27 |
ZA201501254B (en) | 2016-05-25 |
IN2015DN01727A (es) | 2015-05-29 |
AU2013308355B2 (en) | 2017-08-31 |
US9895302B2 (en) | 2018-02-20 |
EP2891487A4 (en) | 2016-04-20 |
MX2015002299A (es) | 2016-02-10 |
MX357601B (es) | 2018-07-16 |
KR102128478B1 (ko) | 2020-07-01 |
PE20150731A1 (es) | 2015-05-17 |
BR102012022034A2 (pt) | 2014-08-19 |
DK2891487T3 (en) | 2019-01-14 |
CN104768539B (zh) | 2019-03-05 |
JP6235018B2 (ja) | 2017-11-22 |
AR092402A1 (es) | 2015-04-22 |
PE20191713A1 (es) | 2019-12-05 |
EP2891487A1 (en) | 2015-07-08 |
ES2702577T3 (es) | 2019-03-04 |
CA2883996A1 (en) | 2014-03-06 |
WO2014032151A1 (pt) | 2014-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY35003A (es) | Nanopartícula polimérica de finasterida, suspensión acuosa conteniendo a la misma, composición para tratamiento de alopecia,proceso de preparación de dicha composición, y su uso | |
UY35002A (es) | Nanopartícula polimérica de finasterida y minoxidil, proceso de preparación, suspensión acuosa conteniendo la misma, composición farmacéutica, y su uso | |
SV2017005487A (es) | Derivados de 4h-pirrol[3,2-c]piridin-4-ona | |
CL2015003801A1 (es) | Formulaciones de anticuerpos y metodos | |
MX369491B (es) | Compuestos tricíclicos como agentes anticancerígenos. | |
MX2016004759A (es) | Composiciones para trampas de oxidos de nitrogeno (nox) pobres. | |
BR112015023629A2 (pt) | formulação de acetato de abiraterona | |
MX2016001788A (es) | Derivados de benzimidazolil-metil urea como agonistas del receptor de alx. | |
EA202090547A3 (ru) | Макроциклические деаза-оксипурины для лечения вирусных инфекций | |
UA113651C2 (xx) | Макроциклічні пурини для лікування вірусних інфекцій | |
UY33503A (es) | Imidazo [1,2-a]pirimidinas y piridinas sustituidas | |
MX2015010106A (es) | Moduladores de la proteina activadora de 5-lipoxigenasa. | |
CU24360B1 (es) | Derivados de ácido heteroaril butanoico como inhibidores de lta4h | |
PH12014502465A1 (en) | Fluorinated bridged spiro[2.4]heptane derivatives as alx receptor agonists | |
PH12016500924A1 (en) | Anti-cancer agents and preparation thereof | |
MX2016001138A (es) | Compuestos de benzoxaborol triciclico, metodo de preparacion y uso del mismo. | |
BR112015031820A2 (pt) | composto, composição farmacêutica, intermediário, processo para a preparação de um composto e métodos | |
MX362905B (es) | Tratamiento de combinacion. | |
EA201400444A1 (ru) | Производные 2-оксопиперидинила | |
CL2012003208A1 (es) | Metodo de preparacion de 11-isobutil-2-metil-8-(2-pirimidinil amino)-2,5,6,11,12,13-hexahidro-4hindazolo[5,4-a]pirrolo[3,4-c]carbazol-4-ona; compuesto intermediatrio; metodo de preparacion del compuesto intermediario; util como agente antitumoral y antiangiogenico. | |
UA106101C2 (uk) | Спосіб виготовлення медичних противірусних препаратів, що містять наночастинки, та препарат проти вірусів герпесу hiv і грипу h1n1, виготовлений за даним способом |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RDES | Application refused |
Effective date: 20220517 |